Adicet Bio
ACET
$1.68
Share price
-7.18%
Change (1 day)
-70.93%
Change (1 year)
Categories
Adicet Bio (ACET) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $37.12 M
According to Adicet Bio's latest financial reports the company's total liabilities are $37.12 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Adicet Bio - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $38.35 M | 7.1% |
| 2021-12-31 | $35.8 M | -18.63% |
| 2020-12-31 | $44 M | -69% |
| 2019-12-31 | $0.14 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $53.19 B | 143,205.50% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 369,547.09% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 185,891.38% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 95,139.76% | 🇮🇱 Israel |
 Hawkins HWKN | $0.25 B | 574.28% | 🇺🇸 USA |
 Quaker Houghton KWR | $1.32 B | 3,481.06% | 🇺🇸 USA |